Synapse - Works

Results (22057)

KEYNOTE-057: Phase 2 study of pembrolizumab for patients (pts) with Bacillus Calmette Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC)

Meeting Abstract

Kamat, A. M.; Bellmunt, J.; Choueiri, T. K.; Nam, K.; De Santis, M.; Dreicer, R.; Hahn, N. M.; Perini, R. F.; Siefker-Radtke, A. O.; Sonpavde, G.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype

Meeting Abstract

Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection

Meeting Abstract

Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

CheckMate-032: Phase I/II open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC)

Meeting Abstract

Janjigian, Y. Y.; Bendell, J. C.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Ott, P. A.; Bono, P.; Jaeger, D.; Evans, T. R. J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Preliminary results of ENCORE 601, a phase 1 b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Johnson, M. L.; Adjei, A. A.; Ramalingam, S. S.; Janne, P. A.; Dominguez, G.; Gabrilovich, D.; Deleon, L.; Hasapidis, J. L.; Diede, S. J.; Ordentlich, P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase I evaluation of the PI3 kinase (PI3K) inhibitor taselisib (GDC-0032) in multiple locally advanced or metastatic PIK3CA mutant solid tumor types

Meeting Abstract

Jhaveri, K. L.; Bedard, P. L.; Cejalvo, J. M.; Hart, L. L.; Juric, D.; Kelly, K.; Lockhart, A. C.; Melnyk, A.; Moore, K. N.; Nemunaitis, J. J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)

Meeting Abstract

Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503

Meeting Abstract

Innocenti, F.; Owzar, K.; Jiang, C.; Sibley, A.; Mulkey, F.; Carey, L. A.; Tripathy, D.; Schneider, B. P.; Barry, W. T.; Winer, E. P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors

Meeting Abstract

Hyman, D. M.; Tran, B.; Jaime, J. C.; Garralda, E.; Machiels, J. P. H.; Schellens, J. H. M.; Bedard, P.; Campone, M.; Cassier, P.; Sarantopoulos, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save